Comparative efficacy of PCR-based restriction fragment length polymorphism (RFLP) & multiplex PCR for glycoprotein B (gB) genotyping of human cytomegalovirus

Indian Journal of Medical Research

Volumn 126, Issue 2, 2007, Pages 122-127

  Sowmya, P ^a   Dhanya, V ^a   Madhavan, H N ^a   Therese, K L ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

gB genotypes; Human cytomegalovirus; Multiplex nested PCR; PCR based RFLP

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GLYCOPROTEIN B;

ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOASSAY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS STRAIN; VIRUS TRANSMISSION;

COST-BENEFIT ANALYSIS; GENOME, VIRAL; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SENSITIVITY AND SPECIFICITY; VIRAL ENVELOPE PROTEINS;

EID: 35648972094     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Van der Bij W, Speich R. Management of cytomegalovirus infections and disease after solid-organ transplantation. Clin Infect Dis 2001; 33 (Suppl): 33-7.
2. Chou S, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization related epitopes. J Infect Dis 1991; 163: 1229-34.
3. Lurain NS, Kapell KS, Huang DD, Short JA, Painstil J, Winkfield E, et al. Human cytomegalovirus UL 144 open reading frame: Sequence hypervariability in low passage clinical isolates. J Virol 1999; 73: 10040-50.
4. Chou SW. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis 1990; 162: 738-42.
5. Shepp DH, Match ME, Lipson SM, Pergolizzi RG. A fifth human cytomegalovirus glycoprotein B genotype. Res Virol 1998; 149: 109-14.
6. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004; 39: 155-61.
7. Arens M. Methods for subtyping and molecular comparison of human viral genomes. Clin Microbiol Rev 1999; 12: 612-26.
8. Tarrago D, Quereda C, Tenorio A. Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J Clin Microbiol 2003; 41: 2872-7.
9. Sowmya P, Madhavan HN, Therese KL. Failure to genotype human cytomegalovirus by PCR-RFLP method due to sequence variation within the primer-binding site. J Virol Methods 2006; 134: 250-1.
10. Ho SKN, Lo CY, Cheng IKP, Chan TM. Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining. J Clin Microbiol 1998; 36: 638-40.
11. Sowmya P, Madhavan HN, Therese KL. Evaluation of three polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of human cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India. Virol J 2006; 3: 20.
12. Priya K. Application of rapid aetiological diagnostic methods on intraocular specimens in viral retinochoroiditis. Indian J Med Res 2001; 115: 242-7.
13. Carraro CF, Granato E. Single human cytomegalovirus gB genotype shed in multiple sites at the time of diagnosis in renal transplant recipients. J Med Virol 2003; 70: 240-3.
14. Adhikary AK, Inada T, Banik U, Numaga J, Okabe N. Identification of subgenus C adenoviruses by fiber-based multiplex PCR. J Clin Microbiol 2004; 42: 670-3.